13.1(top 1%)
impact factor
623(top 50%)
papers
18.5K(top 10%)
citations
73(top 10%)
h-index
13.7(top 1%)
extended IF
827
all documents
23.8K
doc citations
111(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Discovering the anticancer potential of non-oncology drugs by systematic viability profilingNature Cancer2020497
2The impact of the COVID-19 pandemic on cancer careNature Cancer2020424
3Pan-cancer computational histopathology reveals mutations, tumor composition and prognosisNature Cancer2020384
4Pan-cancer image-based detection of clinically actionable genetic alterationsNature Cancer2020377
5Circulating tumor DNA and liquid biopsy in oncologyNature Cancer2020361
6Cancer vaccines: the next immunotherapy frontierNature Cancer2022319
7Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumabNature Cancer2020283
8PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancerNature Cancer2020279
9Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancerNature Cancer2020273
10Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerNature Cancer2020248
11Overcoming therapy resistance in EGFR-mutant lung cancerNature Cancer2021241
12Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myelomaNature Cancer2020233
13Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancerNature Cancer2020232
14Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expressionNature Cancer2021224
15Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancerNature Cancer2020221
16Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunityNature Cancer2020210
17Cancer-associated fibroblasts in the single-cell eraNature Cancer2022207
18A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumorsNature Cancer2021203
19Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancerNature Cancer2022200
20A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependenciesNature Cancer2020195
21Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcomeNature Cancer2020191
22Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesNature Cancer2021190
23Molecular pathogenesis and systemic therapies for hepatocellular carcinomaNature Cancer2022182
24Fatty acid synthesis is required for breast cancer brain metastasisNature Cancer2021176
25Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunityNature Cancer2021176
26A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncologyNature Cancer2022171
27Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncologyNature Cancer2022168
28Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneityNature Cancer2021166
29Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulationNature Cancer2020162
30L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancerNature Cancer2020162
31The metabolic landscape of RAS-driven cancers from biology to therapyNature Cancer2021161
32Artificial intelligence in histopathology: enhancing cancer research and clinical oncologyNature Cancer2022161
33Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsNature Cancer2020159
34Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapyNature Cancer2020153
35Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancerNature Cancer2020149
36Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerNature Cancer2021149
37The current paradigm and challenges ahead for the dormancy of disseminated tumor cellsNature Cancer2020143
38A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinomaNature Cancer2020138
39Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunityNature Cancer2020138
40Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialNature Cancer2021137
41The cGAS–STING pathway and cancerNature Cancer2022137
42A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancyNature Cancer2022136
43EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerNature Cancer2021133
44Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomasNature Cancer2021132
45Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE studyNature Cancer2021129
46Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapyNature Cancer2020126
47Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaNature Cancer2021125
48Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancerNature Cancer2022123
49CD4+ T cells in cancerNature Cancer2023123
50Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemiaNature Cancer2020121